This HTML5 document contains 45 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
n10http://dx.doi.org/10.1002/1097-0142(19931215)72:12%2B%3C3888::
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q72636487
rdf:type
wikibase:Item
schema:description
scientific article published on 01 December 1993 наукова стаття, опублікована в грудні 1993 im Dezember 1993 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu n'avientu de 1993 article scientifique publié en 1993 wetenschappelijk artikel
p:P577
wds:Q72636487-6744F701-BE16-453B-A851-8A48A6A57AF2
wdt:P577
1993-12-01T00:00:00Z
p:P407
wds:Q72636487-9893984C-B07F-4B90-B3CD-AA064F10369F
wdt:P407
wd:Q1860
p:P2093
wds:Q72636487-3BD7F411-8B07-49F3-AEEE-ADA3596D2BAA wds:Q72636487-28320D81-C3EF-4D9C-B32C-4F36850DC4E5
wdt:P2093
G P Murphy L Denis
rdfs:label
Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer
skos:prefLabel
Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer
schema:name
Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer
p:P1476
wds:Q72636487-8F374F07-5C38-49AF-95EE-6989C8F36A08
wdt:P1476
Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer
p:P304
wds:Q72636487-8085B99D-FB5A-4B28-B444-6E79080C891A
wdt:P304
3888-3895
p:P31
wds:Q72636487-0de2082f-80d8-42b2-8d3a-f79f1d218cff wds:Q72636487-369ED3D1-0CCB-4298-9873-D54C38A443B0
wdt:P31
wd:Q815382 wd:Q13442814
p:P921
wds:Q72636487-7ACCAFBC-870D-400E-BB3A-411590342139 wds:Q72636487-498AFABE-593B-488A-A4E0-0C7089C43200
wdt:P921
wd:Q181257 wd:Q42824827
p:P698
wds:Q72636487-59ED50D3-059C-4C3A-9A09-D3FCEC5B1BF2
wdtn:P698
n12:8252511
wdt:P698
8252511
p:P1433
wds:Q72636487-74B8526A-FF4C-4045-9FD3-6594B5717254
wdt:P1433
wd:Q326041
p:P433
wds:Q72636487-D7941C61-40D0-453F-A84D-33ECB84B7F8E
p:P478
wds:Q72636487-10E6A7A8-9428-4BB0-B57A-31A2E4B92E2B
wdt:P433
12 Suppl
wdt:P478
72
p:P356
wds:Q72636487-22DF335D-492B-4A8F-A604-F212B19F5C93
wdtn:P356
n10:AID-CNCR2820721726%3E3.0.CO;2-B
wdt:P356
10.1002/1097-0142(19931215)72:12+<3888::AID-CNCR2820721726>3.0.CO;2-B